Excited to share recent work from our lab in @bloodjournal.bsky.social #BloodAdvances! We studied the impact of CD45-targeted radioimmunotherapy (RIT) on the bone marrow vascular niche. Turns out the vasculature is majorly disrupted by hematopoietic targeted RIT ☢️🩸
shorturl.at/qzWIB
